Home/Cellusion/Takuya Kaneko

TK

Takuya Kaneko

CFO

Therapeutic Areas

Cellusion Pipeline

Drug	Indication	Phase
CECSi Cell Therapy	Bullous Keratopathy	Phase 1/Phase 1 equivalent

Leadership Team at Cellusion

Shin Hatou, M.D., Ph.D.

View full Cellusion profile